Procter & Gamble Health Ltd

P & G Health Ltd Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Procter & Gamble Health Ltd

₹ 4,960 1.99%
25 Sep - close price
pghealthindia.com BSE: 500126 NSE : PGHL
About

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.[1]

Key Points

Brand Portfolio
The company has a strong portfolio of various pharma brands such as Evion, Neurobion, Seven seas, Nasivion, Polybion and Livogen.[1]

Website BSE NSE
  • Market Cap ₹ 8,233 Cr.
  • Current Price ₹ 4,960
  • High / Low ₹ 5,500 / 3,870
  • Stock P/E 35.9
  • Book Value ₹ 452
  • Dividend Yield 1.92 %
  • ROCE 45.6 %
  • ROE 33.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.9%
  • Company has been maintaining a healthy dividend payout of 78.7%

Cons

  • Stock is trading at 11.0 times its book value
  • The company has delivered a poor sales growth of 12.0% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023
201 264 240 219 285 273 278 268 296 298 310 321 301
148 186 151 188 237 195 216 199 237 207 201 241 256
Operating Profit 53 78 89 31 48 78 62 69 59 91 109 80 45
OPM % 26% 30% 37% 14% 17% 29% 22% 26% 20% 31% 35% 25% 15%
11 7 6 3 2 3 5 2 3 3 5 5 5
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 8 7 8 8 7 7 7 6 7 7 8 6 6
Profit before tax 56 77 86 26 44 74 60 65 55 87 105 79 44
Tax % 12% 23% 21% 40% 22% 25% 25% 21% 25% 26% 27% 25% 32%
49 59 68 16 34 55 45 51 41 64 77 59 30
EPS in Rs 29.43 35.70 40.89 9.50 20.42 33.36 27.01 30.82 24.81 38.35 46.27 35.66 17.96
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023
687 798 867 940 993 698 849 927 1,356 1,009 1,114 1,230
582 721 809 855 877 621 701 723 1,037 762 846 905
Operating Profit 106 77 59 85 116 77 148 204 319 246 268 325
OPM % 15% 10% 7% 9% 12% 11% 17% 22% 24% 24% 24% 26%
20 21 20 22 24 74 768 48 66 18 13 18
Interest 0 0 0 0 0 0 0 0 0 1 0 1
Depreciation 9 10 13 23 25 19 21 17 29 30 27 28
Profit before tax 117 88 67 83 115 132 895 234 355 233 253 314
Tax % 33% 37% 35% 36% 31% 29% 6% 32% 28% 24% 24% 27%
78 56 43 54 79 94 839 159 254 177 193 229
EPS in Rs 47.23 33.66 26.04 32.27 47.67 56.57 505.27 95.64 153.07 106.51 115.98 138.24
Dividend Payout % 5% 25% 23% 23% 23% 27% 87% 0% 150% 122% 45% 69%
Compounded Sales Growth
10 Years: 6%
5 Years: 12%
3 Years: -3%
TTM: 10%
Compounded Profit Growth
10 Years: 11%
5 Years: 23%
3 Years: -4%
TTM: 19%
Stock Price CAGR
10 Years: 24%
5 Years: 14%
3 Years: 1%
1 Year: 24%
Return on Equity
10 Years: 27%
5 Years: 37%
3 Years: 28%
Last Year: 34%

Balance Sheet

Figures in Rs. Crores

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023
17 17 17 17 17 17 17 17 17 17 17 17
Reserves 467 506 538 575 647 717 1,524 800 890 687 600 734
0 0 0 0 0 0 0 0 0 8 3 12
111 125 154 192 215 258 219 250 269 275 274 338
Total Liabilities 594 648 708 784 879 991 1,759 1,067 1,176 986 894 1,101
75 85 110 132 111 115 104 101 101 104 112 144
CWIP 2 9 28 7 30 9 17 11 21 39 41 32
Investments 24 24 24 42 28 70 0 0 0 0 0 0
494 530 547 603 711 797 1,639 954 1,053 843 741 925
Total Assets 594 648 708 784 879 991 1,759 1,067 1,176 986 894 1,101

Cash Flows

Figures in Rs. Crores

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023
54 0 5 83 107 54 -130 235 247 170 236
-82 7 11 -68 -75 -48 1,270 165 -32 -26 -22
0 -5 -17 -12 -15 -22 -30 -883 -387 -289 -98
Net Cash Flow -28 3 -1 4 17 -16 1,109 -483 -172 -145 116

Ratios

Figures in Rs. Crores

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023
Debtor Days 34 38 44 49 39 64 28 30 26 22 27 34
Inventory Days 160 153 162 140 145 243 154 139 113 138 124 136
Days Payable 48 37 40 55 67 128 124 106 105 209 189 239
Cash Conversion Cycle 146 154 166 134 118 179 58 63 34 -49 -38 -69
Working Capital Days 77 70 74 69 52 94 42 22 23 9 18 16
ROCE % 26% 18% 12% 15% 18% 16% 78% 20% 29% 29% 38% 46%

Shareholding Pattern

Numbers in percentages

Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023
51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82%
5.29% 6.15% 6.71% 6.45% 5.88% 5.97% 6.57% 6.47% 6.05% 6.33% 6.72% 7.15%
11.94% 11.72% 11.48% 11.81% 8.36% 8.53% 7.91% 8.07% 12.62% 12.44% 12.31% 12.29%
30.96% 30.31% 30.00% 29.93% 33.94% 33.69% 33.71% 33.64% 29.51% 29.41% 29.14% 28.74%
No. of Shareholders 49,30350,32153,07658,81863,52565,53766,28965,72965,14863,83161,03058,856

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Nov 2022
    Transcript
    Notes
    PPT
  • May 2018
    Transcript
    Notes
    PPT